Lauxera Capital Partners invests in Caresyntax
Lauxera Capital Partners has made an investment in Caresyntax as part of a USD100 million Series C fundraise. Other new investors include PFM Health Sciences LP, Optum Ventures, Intel Capital, Vesalius Biocapital Partners, Arno Capital, and Reyazat Investments. Existing investors Relyens, IPF Partners, and Surgical.AI also participated in the round.